Biotech Archives - Page 26 of 733

1 minute read

MIRA Pharmaceuticals Discusses With Memorial Sloan Kettering To Collaborate On A Preclinical Cancer Pain Model Utilizing The Co’s Novel Oral Ketamine Analog

May 21, 8:49 AM

Ketamir-2, the Company's novel oral ketamine analog in development, aims to provide a safe and effective alternative for managing cancer pain and associated depressionMIAMI, May 21, 2024 /PRNewswire/ -- MIRA

MIRA

1 minute read

Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 Mo…

By Benzinga Newsdesk

May 21, 8:38 AM

Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa's Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for

BDRX

1 minute read

GSK’s Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows

By Vandana Singh

May 21, 8:31 AM

GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe asthma exacerbations.

GSK

1 minute read

Vir Biotechnology’s SOLSTICE Data To Be Featured At The European Association For The Study Of The Liver Congress 2024

By Benzinga Newsdesk

May 21, 8:30 AM

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the EASL Congress has changed the Company's Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The SOLSTICE data will be

VIR

1 minute read

NewAmsterdam Pharma Presents New Clinical And Preclinical Data On Obicetrapib’s Impact On Key Risk Factors For Cardiovascular Disease At Upcoming Medical Meetings

By Benzinga Newsdesk

May 21, 8:25 AM

-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib's impact on key lipid and lipoprotein biomarkers -- -- On track to report topline data from Phase 3

NAMS

1 minute read

ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development

By Vandana Singh

May 21, 8:24 AM

Sanofi collaborates with OpenAI and Formation Bio to enhance drug development. The partnership leverages proprietary data, advanced AI models, and engineering expertise to accelerate the biopharma lifecycle.

MRNA

1 minute read

Tonix Pharmaceuticals Reports Key Findings From Initial Phase Of EVERSANA Market Opportunity Analysis For Tonmya For The Management Of Fibromyalgia

By Benzinga Newsdesk

May 21, 8:14 AM

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials Primary physician research found

TNXP

1 minute read

Morphic Therapeutic Announced The Presentation Of New Data Demonstrating Novel Real-Time Visualization Of Small Molecule α4β7 Inhibition Of Gut-Trafficking Cells

By Benzinga Newsdesk

May 21, 8:11 AM

-α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclonal Antibody

MORF

1 minute read

Three Publications Demonstrate Bionano’s OGM’s Utility For Cell And Gene Therapy; Publications Include Niño Jesús University Children’s Hospital; Ruhr-University Bochum And Janssen

By Benzinga Newsdesk

May 21, 8:09 AM

Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for cell and gene therapy development that allows researchers in academic medical centers and

BNGO

2 minute read

AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion

By Vandana Singh

May 21, 7:16 AM

AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.

AZN